2012
DOI: 10.1016/s1470-2045(12)70340-6
|View full text |Cite
|
Sign up to set email alerts
|

Abdominal radiation and diabetes: one more piece in the puzzle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 9 publications
1
7
0
1
Order By: Relevance
“…The downregulation of GCGa (p = 0.032) was also validated using qPCR (Figure 7). Similarly the upregulation of SREBF1 which is known to modulate insulin sensitivity [85] is in line with the literature showing that radiation exposure can lead to insulin resistance [86]. In addition, the upregulation of KLF7 might suggest a decrease in insulin secretion [87].…”
Section: Pathway Analysis Of Induced Torpor With Radiation Reveals Stress Response With Prosurvival Signalssupporting
confidence: 85%
“…The downregulation of GCGa (p = 0.032) was also validated using qPCR (Figure 7). Similarly the upregulation of SREBF1 which is known to modulate insulin sensitivity [85] is in line with the literature showing that radiation exposure can lead to insulin resistance [86]. In addition, the upregulation of KLF7 might suggest a decrease in insulin secretion [87].…”
Section: Pathway Analysis Of Induced Torpor With Radiation Reveals Stress Response With Prosurvival Signalssupporting
confidence: 85%
“…One recent analysis of 2520 childhood solid tumor and lymphoma survivors suggested that diabetes risk plateaus at doses of 20–29 Gy to the pancreatic tail, while a subsequent study of Hodgkin lymphoma survivors demonstrated a linear radiation dose–response relationship without any such plateau . Both of these studies, as well as the prior analysis from the Childhood Cancer Survivor Study, found that the association between diabetes risk and pancreatic radiation was independent of body mass index (BMI), thus leading investigators to surmise that treatment‐related diabetes is secondary to β‐cell dysfunction, and not obesity …”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, they observed a four-fold increased risk of hyperparathyroidism, an observation that has not, to our knowledge, been previously reported. Also hidden amongst the details, but a topic of recent discussion, 5-7 was a 60% increased risk of diabetes. Similarly, it is notable that survivors from all 13 cancer groups had an overall elevated risk of developing an endocrinopathy.…”
mentioning
confidence: 99%